Brand Name | Status | Last Update |
---|---|---|
anktiva | Biologic Licensing Application | 2024-05-09 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Carcinoma | D002277 | — | C80.0 | 1 | — | — | — | — | 1 |
Squamous cell carcinoma of head and neck | D000077195 | — | — | 1 | — | — | — | — | 1 |
Squamous cell carcinoma | D002294 | — | — | 1 | — | — | — | — | 1 |
Drug common name | Inbakicept |
INN | inbakicept |
Description | Inbakicept is a protein pharmaceutical. It is currently being investigated in clinical studies. |
Classification | Protein |
Drug class | receptor molecules or membrane ligands, natural, modified or modified |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | CHEMBL4594318 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | QN4LI58PJ5 (ChemIDplus, GSRS) |